19-11059755-C-T
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP6BS1
The NM_001387283.1(SMARCA4):c.4734C>T(p.Ile1578Ile) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000727 in 1,568,398 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001387283.1 splice_region, synonymous
Scores
Clinical Significance
Conservation
Publications
- Coffin-Siris syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Illumina
- intellectual disability, autosomal dominant 16Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- rhabdoid tumor predisposition syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- uterine corpus sarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- familial rhabdoid tumorInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary nonpolyposis colon cancerInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SMARCA4 | NM_001387283.1 | c.4734C>T | p.Ile1578Ile | splice_region_variant, synonymous_variant | Exon 34 of 36 | ENST00000646693.2 | NP_001374212.1 | |
| SMARCA4 | NM_003072.5 | c.4638C>T | p.Ile1546Ile | splice_region_variant, synonymous_variant | Exon 33 of 35 | ENST00000344626.10 | NP_003063.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SMARCA4 | ENST00000646693.2 | c.4734C>T | p.Ile1578Ile | splice_region_variant, synonymous_variant | Exon 34 of 36 | NM_001387283.1 | ENSP00000495368.1 | |||
| SMARCA4 | ENST00000344626.10 | c.4638C>T | p.Ile1546Ile | splice_region_variant, synonymous_variant | Exon 33 of 35 | 1 | NM_003072.5 | ENSP00000343896.4 | ||
| SMARCA4 | ENST00000643549.1 | c.4644C>T | p.Ile1548Ile | splice_region_variant, synonymous_variant | Exon 33 of 35 | ENSP00000493975.1 | ||||
| SMARCA4 | ENST00000541122.6 | c.4548C>T | p.Ile1516Ile | splice_region_variant, synonymous_variant | Exon 33 of 35 | 5 | ENSP00000445036.2 | |||
| SMARCA4 | ENST00000643296.1 | c.4548C>T | p.Ile1516Ile | splice_region_variant, synonymous_variant | Exon 32 of 34 | ENSP00000496635.1 | ||||
| SMARCA4 | ENST00000644737.1 | c.4548C>T | p.Ile1516Ile | splice_region_variant, synonymous_variant | Exon 32 of 34 | ENSP00000495548.1 | ||||
| SMARCA4 | ENST00000589677.5 | c.4545C>T | p.Ile1515Ile | splice_region_variant, synonymous_variant | Exon 33 of 35 | 5 | ENSP00000464778.1 | |||
| SMARCA4 | ENST00000643995.1 | c.4059C>T | p.Ile1353Ile | splice_region_variant, synonymous_variant | Exon 30 of 32 | ENSP00000496004.1 | ||||
| SMARCA4 | ENST00000644963.1 | c.3288C>T | p.Ile1096Ile | splice_region_variant, synonymous_variant | Exon 26 of 28 | ENSP00000495599.1 | ||||
| SMARCA4 | ENST00000644065.1 | c.3270C>T | p.Ile1090Ile | splice_region_variant, synonymous_variant | Exon 25 of 27 | ENSP00000493615.1 | ||||
| SMARCA4 | ENST00000642350.1 | c.3132C>T | p.Ile1044Ile | splice_region_variant, synonymous_variant | Exon 25 of 27 | ENSP00000495355.1 | ||||
| SMARCA4 | ENST00000643857.1 | c.2898C>T | p.Ile966Ile | splice_region_variant, synonymous_variant | Exon 23 of 25 | ENSP00000494159.1 | ||||
| SMARCA4 | ENST00000538456.4 | c.702C>T | p.Ile234Ile | splice_region_variant, synonymous_variant | Exon 6 of 8 | 3 | ENSP00000495197.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152226Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000170 AC: 3AN: 176742 AF XY: 0.0000106 show subpopulations
GnomAD4 exome AF: 0.0000784 AC: 111AN: 1416172Hom.: 0 Cov.: 32 AF XY: 0.0000800 AC XY: 56AN XY: 700320 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152226Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74368 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:2
In silico analysis suggests this variant may impact gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 32686686) -
The SMARCA4 c.4734C>T (p.Ile1578=) synonymous variant has not been reported in individuals with SMARCA4-related conditions in the published literature. The frequency of this variant in the general population, 0.000045 (4/88184 chromosomes (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is uninformative in the assessment of its pathogenicity. Analysis of this variant using software algorithms for the prediction of the effect of nucleotide changes on splicing yielded predictions that this variant does not affect SMARCA4 mRNA splicing. Based on the available information, we are unable to determine the clinical significance of this variant. -
Rhabdoid tumor predisposition syndrome 2 Benign:1
- -
Hereditary cancer-predisposing syndrome Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at